Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: patientman
It is no mystery. in the space of a little more than a year S & L diluted the OS by about 100 million shares. As I've said before, I believe that the warrant issue is nearing an end and that S & L will soon become just a large shareholder. Then hopefully the BOD will revisit the dividend, which had a dilutive effect on the stock especially when it was also given to warrant holders, and concentrate on a more agressive share repurchase program.

Jul 10, 2007 07:02AM

Jul 10, 2007 07:25AM

Jul 10, 2007 07:27AM

Jul 10, 2007 07:34AM

Jul 10, 2007 07:46AM
SGE

Jul 10, 2007 07:53AM

Jul 10, 2007 08:00AM

Jul 10, 2007 08:03AM

Jul 10, 2007 08:06AM

Jul 10, 2007 08:10AM

Jul 10, 2007 08:14AM

Jul 10, 2007 08:17AM

Jul 10, 2007 08:28AM

Jul 10, 2007 08:44AM

Jul 10, 2007 08:47AM

Jul 10, 2007 08:55AM

Jul 10, 2007 08:56AM

Jul 10, 2007 09:01AM
Share
New Message
Please login to post a reply